Page last updated: 2024-12-06

phosphamidon

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

Phosphamidon: An organophosphate cholinesterase inhibitor that is used as an insecticide. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID3032604
CHEMBL ID1892391
SCHEMBL ID27697
MeSH IDM0016634

Synonyms (96)

Synonym
phosphoric acid, dimethyl ester, ester with 2-chloro-n,n-diethyl-3-hydroxycrotanamide, (z)-
(z)-phosphamidon
cis-phosphamidon
phosphoric acid, (1z)-2-chloro-3-(diethylamino)-1-methyl-3-oxo-1-propenyl-, dimethyl ester
(z)-2-chloro-n,n-diethyl-3-hydroxycrotonamide dimethyl phosphorate
dimethyl phosphate of 2-chloro-n,n-diethyl-3-hydroxycrotonamide
phosphoric acid, dimethyl ester, ester with 2-chloro-n,n-diethyl-3-hydroxycrotonamide
phosphoric acid, 2-chloro-3-(diethylamino)-1-methyl-3-oxo-1-propenyl dimethyl ester
(2-cloro-3-dietilamino-1-metil-3-oxo-prop-1-en-il)-dimetil-fosfato [italian]
(2-chloor-3-diethylamino-1-methyl-3-oxo-prop-1-en-yl)-dimethyl-fosfaat [dutch]
(o,o-dimethyl-o-(1-methyl-2-chloro-2-diethylcarbamoyl-vinyl) phosphate)
hsdb 1754
ccris 516
merkon
2-chloro-2-diethylcarbamoyl-1-methylvinyl dimethylphosphate
dimethyl phosphate ester with 2-chloro-n,n-diethyl-3-hydroxycrotonamide
dimethyl 2-chloro-2-diethylcarbamoyl-1-methylvinyl phosphate
nci-c00588
apamidon
famfos
c 570
einecs 236-116-5
phosphamidon 85 wsc
phosphamidone
dimecron
dimecron 100
fosfamidone [italian]
2-chloro-n,n-diethyl-3-hydroxycrotonamide dimethyl phosphate
ai3-25515
o,o-dimethyl-o-(1-methyl-2-chlor-2-n,n-diaethyl-carbamoyl)-vinyl-phosphat [german]
dimethyl diethylamido-1-chlorocrotonyl (2) phosphate
ciba 570
n,n-diethyl 2-chloro-3-dimethylphosphate crotonamide
ent 25515
fosfamidon [dutch]
caswell no. 661
oms 1325
2-chloro-2-diethylcarbamyl-1-methylvinyl-dimethyl phosphate
phosphamidon [ansi:bsi:iso]
(2-chlor-3-diaethylamino-1-methyl-3-oxo-prop-1-en-yl)-dimethyl-phosphat [german]
2-chloro-n,n-diethyl-3-hydroxycrotonamide ester with dimethyl phosphate
sundaram 1975
crotonamide, 2-chloro-n,n-diethyl-3-hydroxy-, dimethyl phosphate
dixon
foszfamidon (hungarian)
phosphate de dimethyle et de (2-chloro-2-diethylcarbamoyl-1-methyl-vinyle) [french]
epa pesticide chemical code 018201
NCGC00166317-01
2-chloro-3-(diethylamino)-1-methyl-3-oxoprop-1-en-1-yl dimethyl phosphate
phosphamidon
13171-21-6
o,o-dimethyl o-(2-chloro-2-(n,n-diethylcarbamoyl)-1-methylvinyl) phosphate
2-chloro-2-dimethylcarbamoyl-1-methylvinyl dimethyl phosphate
2-chloro-3-dimethoxyphosphinoyloxy-n,n-diethylbut-2-enamide
NCGC00166317-02
C18689
(2-chlor-3-diaethylamino-1-methyl-3-oxo-prop-1-en-yl)-dimethyl-phosphat
(2-chloor-3-diethylamino-1-methyl-3-oxo-prop-1-en-yl)-dimethyl-fosfaat
7h857a6n6h ,
fosfamidone
phosphate de dimethyle et de (2-chloro-2-diethylcarbamoyl-1-methyl-vinyle)
fosfamidon
unii-7h857a6n6h
o,o-dimethyl-o-(1-methyl-2-chlor-2-n,n-diaethyl-carbamoyl)-vinyl-phosphat
(2-cloro-3-dietilamino-1-metil-3-oxo-prop-1-en-il)-dimetil-fosfato
NCGC00256550-01
cas-13171-21-6
dtxcid201156
tox21_302848
tox21_112409
tox21_202100
NCGC00259649-01
unii-hq7958q90z
23783-98-4
hq7958q90z ,
2-chloro-n,n-diethyl-3-(dimethylphosphono)crotonic amide
(z)-2-chloro-2-diethylcarbamoyl-1-methylvinyl dimethyl phosphate
phosphamidon, cis-
phosphoric acid, (1z)-2-chloro-3-(diethylamino)-1-methyl-3-oxo-1-propen-1-yl dimethyl ester
phosphamidon, z isomer
phosphamidon, (z)-
SCHEMBL27697
phosphamidon peak # 2
RGCLLPNLLBQHPF-UHFFFAOYSA-N
CHEMBL1892391
foszfamidon
RGCLLPNLLBQHPF-HJWRWDBZSA-N
dimecron 50
dimecron-20
J-006041
Q424889
dimethyl[2-chloro-1-m-2-(n,n-dimethylcarbamoyl)vinyl]phosphate
Q27280053
1ST20655
z-phosphamidon
DTXSID601030915

Research Excerpts

Toxicity

Phosphamidon appears to affect the principal cells indirectly through its toxic effect on the Leydig cells. On the other hand, monocrotophos, dicrotophos and phosphamidon were somewhat more toxic to the young rat. The magnitude of the differences was < 2-fold lower.

ExcerptReferenceRelevance
"For the evaluation of possible adverse effects of compounds in fish at sublethal doses a dynamic system is required."( A dynamic system for long-term toxicity studies in fish under laboratory conditions.
Bathe, R, 1979
)
0.26
" An enhanced toxic impact is indicated when the pesticides are present together rather than as individual compounds."( Individual and combined toxicity of common pesticides to teleost Puntius conchonius Hamilton.
Gill, TS; Pande, J; Tewari, H, 1991
)
0.28
"4 mg/kg - dose 1/4th of LD50 given ip), produced several autonomic, neurological and behavioral effects in mice with peak effects being at 15 min."( Acute neurobehavioural toxicity of phosphamindon and its drug-induced alteration.
Agarwal, AK; Sankaranarayanan, A; Sharma, PL, 1990
)
0.28
" Vitamin C doses, when administered alone, did not produce any adverse effect on sperm count and sperm head morphology."( Ameliorating effect of vitamin C on murine sperm toxicity induced by three pesticides (endosulfan, phosphamidon and mancozeb).
Khan, PK; Sinha, SP, 1996
)
0.29
" Phosphamidon appears to affect the principal cells indirectly through its toxic effect on the Leydig cells; the clear cells of the cauda appear to be directly vulnerable to the toxic action of the pesticide."( Male reproductive toxicity of phosphamidon: histopathological changes in epididymis.
Akbarsha, MA; Sivasamy, P, 1998
)
0.3
" On the other hand, monocrotophos, dicrotophos, and phosphamidon were somewhat more toxic to the young rat, but the magnitude of the differences was < 2-fold lower."( Age-related differences in acute neurotoxicity produced by mevinphos, monocrotophos, dicrotophos, and phosphamidon.
Moser, VC,
)
0.13
" Thus, GE can be considered as an effective, economical and safe extract to circumvent PHO-induced hepatotoxicity."( Ginger extract ameliorates phosphamidon induced hepatotoxicity.
Babu, SP; Mukherjee, N; Mukherjee, S; Roy, P; Saini, P, 2015
)
0.42

Bioavailability

ExcerptReferenceRelevance
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51

Dosage Studied

ExcerptRelevanceReference
" In the experiments both in vitro and in vivo, the analysis of the frequencies of the abnormal cells and of the chromosome lesion types support the existence of a dose-response correlation."( The comparative cytogenetic effects of aldrin and phosphamidon.
Georgian, L, 1975
)
0.25
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (12)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
acetylcholinesteraseHomo sapiens (human)Potency37.22040.002541.796015,848.9004AID1347395; AID1347398
GLI family zinc finger 3Homo sapiens (human)Potency0.21690.000714.592883.7951AID1259369
AR proteinHomo sapiens (human)Potency25.99540.000221.22318,912.5098AID743063
progesterone receptorHomo sapiens (human)Potency5.57590.000417.946075.1148AID1346795
retinoid X nuclear receptor alphaHomo sapiens (human)Potency22.38450.000817.505159.3239AID1159531
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency0.00880.001530.607315,848.9004AID1224841
pregnane X nuclear receptorHomo sapiens (human)Potency35.16580.005428.02631,258.9301AID1346982; AID1346985
estrogen nuclear receptor alphaHomo sapiens (human)Potency5.91690.000229.305416,493.5996AID743075; AID743079
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency31.44170.001019.414170.9645AID743191
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency1.36850.001723.839378.1014AID743083
activating transcription factor 6Homo sapiens (human)Potency0.11220.143427.612159.8106AID1159516
peripheral myelin protein 22Rattus norvegicus (Norway rat)Potency0.00810.005612.367736.1254AID624032
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID504749qHTS profiling for inhibitors of Plasmodium falciparum proliferation2011Science (New York, N.Y.), Aug-05, Volume: 333, Issue:6043
Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (124)

TimeframeStudies, This Drug (%)All Drugs %
pre-199056 (45.16)18.7374
1990's38 (30.65)18.2507
2000's18 (14.52)29.6817
2010's11 (8.87)24.3611
2020's1 (0.81)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (2.26%)6.00%
Case Studies4 (3.01%)4.05%
Observational0 (0.00%)0.25%
Other126 (94.74%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]